Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dave Wright

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Prenatal Diagnosis|October 10, 2006
CT ratios: parameter estimates are inconsistent with SURUSS publications?Dave Wright, Ian Bradbury, Peter Benn, et al.
Human Reproduction (Oxford, England)|June 12, 2008
Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-AKarl O Kagan, Dave Wright, Catalina Valencia, et al.
Reproductive Biology and Endocrinology : RB&E|November 2, 2010
First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum markerNiels Tørring, Susan Ball, Dave Wright, et al.
Clinical Chemistry|September 23, 2006
Reproducibility of risk figures in 2nd-trimester maternal serum screening for down syndrome: comparison of 2 laboratoriesPeter A Benn, Gregory S Makowski, James F X Egan, et al.
Plos One|February 20, 2016
Measuring Progress on the Control of Porcine Reproductive and Respiratory Syndrome (PRRS) at a Regional Level: The Minnesota N212 Regional Control Project (Rcp) as a Working ExamplePablo Valdes-Donoso, Lovell S Jarvis, Dave Wright, et al.
Prenatal Diagnosis|April 25, 2006
Three-stage contingent screening for Down syndromeDave Wright, Ian Bradbury, Howard Cuckle, et al.
Prenatal Diagnosis|October 26, 2011
Intraoperator and interoperator repeatability of manual and semi-automated measurement of increased fetal nuchal translucency according to the operator's experienceKarl Oliver Kagan, Harald Abele, Britta Yazdi, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 28, 2022
Effect of race on the measurement of angiogenic factors for prediction and diagnosis of pre-eclampsiaAlan Wright, Peter von Dadelszen, Laura A Magee, et al.
Health Technology Assessment (Winchester, England)|February 14, 2015
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosisSusan Ball, Jane Vickery, Jeremy Hobart, et al.
Prenatal Diagnosis|January 26, 2012
Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011Peter Benn, Antoni Borrell, Howard Cuckle, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Prenatal Diagnosis|October 10, 2006
CT ratios: parameter estimates are inconsistent with SURUSS publications?Dave Wright, Ian Bradbury, Peter Benn, et al.
Human Reproduction (Oxford, England)|June 12, 2008
Screening for trisomies 21, 18 and 13 by maternal age, fetal nuchal translucency, fetal heart rate, free beta-hCG and pregnancy-associated plasma protein-AKarl O Kagan, Dave Wright, Catalina Valencia, et al.
Reproductive Biology and Endocrinology : RB&E|November 2, 2010
First trimester screening for trisomy 21 in gestational week 8-10 by ADAM12-S as a maternal serum markerNiels Tørring, Susan Ball, Dave Wright, et al.
Clinical Chemistry|September 23, 2006
Reproducibility of risk figures in 2nd-trimester maternal serum screening for down syndrome: comparison of 2 laboratoriesPeter A Benn, Gregory S Makowski, James F X Egan, et al.
Plos One|February 20, 2016
Measuring Progress on the Control of Porcine Reproductive and Respiratory Syndrome (PRRS) at a Regional Level: The Minnesota N212 Regional Control Project (Rcp) as a Working ExamplePablo Valdes-Donoso, Lovell S Jarvis, Dave Wright, et al.
Prenatal Diagnosis|April 25, 2006
Three-stage contingent screening for Down syndromeDave Wright, Ian Bradbury, Howard Cuckle, et al.
Prenatal Diagnosis|October 26, 2011
Intraoperator and interoperator repeatability of manual and semi-automated measurement of increased fetal nuchal translucency according to the operator's experienceKarl Oliver Kagan, Harald Abele, Britta Yazdi, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|September 28, 2022
Effect of race on the measurement of angiogenic factors for prediction and diagnosis of pre-eclampsiaAlan Wright, Peter von Dadelszen, Laura A Magee, et al.
Health Technology Assessment (Winchester, England)|February 14, 2015
The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosisSusan Ball, Jane Vickery, Jeremy Hobart, et al.
Prenatal Diagnosis|January 26, 2012
Prenatal Detection of Down Syndrome using Massively Parallel Sequencing (MPS): a rapid response statement from a committee on behalf of the Board of the International Society for Prenatal Diagnosis, 24 October 2011Peter Benn, Antoni Borrell, Howard Cuckle, et al.
Pageof 3